chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Headache; Fever; Chills; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), PYREXIA (Fever) and CHILLS (Chills) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Jun-2021, the patient experienced HEADACHE (Headache), PYREXIA (Fever) and CHILLS (Chills). At the time of the report, HEADACHE (Headache), PYREXIA (Fever) and CHILLS (Chills) was resolving.            Reporter did not allow further contact
There were no seriousness criteria reported. Based upon appropriate medical judgement this case was considered as important medical event (OMIC). From initial information received on 7/7/04 from a health care professional regarding an adverse event occurring in the USA< it was reported that an 18 year old male patient received his first dose of MENOMUNE, lot number UE112AB, administered SC in an unspecified site on 7/1/04 at 3:30 PM. 85 minutes later, at 4:55 PM, the patient developed shortness of breath and itching and felt as if his throat was closing. He was taken to the hospital emergency room and was diagnosed with systemic allergic reaction secondary to vaccination. Reportedly, the patient is highly allergic to peanuts and did admit to having a cupcake with peanut butter icing the day of vaccination at 11:30 AM. It was reported that the patient recovered from the events. From additional information received on 8/19/04, it was reported that the patient had a cookie with peanut butter icing not a cupcake as previously reported. The patient's full name and address was provided as well as the county where the product was administered. It was also reported that the patient was vaccinated at a university health center and the vaccine was purchased with private funds. No additional relevant information has been obtained for the adverse experiences; this follow up report is not submitted to health authorities. From a telephone call received on 9/13/04 from the initial reporter, any additional information requested for this case will be in the emergency room records, which the reporter does not have. She provided the name and address of the hospital where these records could be obtained. No new medical information was reported at this time. No additional relevant information has been obtained for the reported adverse events; this follow up is not submitted to health authorities. From additional information received on 10/11/04 from the treating facility, it was reported that approximately 45 minutes after receiving the vaccine (previously reported as 85 minutes), the patient experienced throat swelling with increased difficulty of breathing, itchy hands, generalized hives and a non-productive cough. A chest x-ray, neck x-ray and electrocardiogram were within normal limits. The patient was treated with Benadryl, Solu-Medrol, and Zantac. He was placed on supplemental oxygen at 2 liters per minute via nasal cannula. The patient recovered from these events. No further information is anticipated; this case is considered closed. (OMIC)
Guillian Barre syndrome starting approximately 1-5 days after vaccination. Seen in the office for symptoms 20 days after vaccination sent for EMG the same day and verified diagnosis. Currently awaiting treatment due to insurance delays.
Patients mother filled out vaccination form with the incorrect age stating patient was 19 years old, claim went through insurance with the incorrectly input age, patient did not provide ID stating they did not have ID, event was noticed after the fact when the pharmacist went to vaccinate the brother and noticed their dates of birth were too close and verified with the father the patient was only 16 years old. patient was monitored for over 1 hour and did not exhibit or complain of any adverse events.
Fever, diarrhea.  Vomiting,  body aches, headache, back of neck aches, pain at site of shot
4 hours after my flu injection the site became painful, red, hot to touch and evolved into a 14 cm round area of redness that was hot to touch.   24 hours after the injection the was also swollen and itchy.  48 hours after the injection the symptoms began to slowly resolve.
This spontaneous report as received from a medical assistant and refers to a currently 16 years-old patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On an unknown date, the patient was vaccinated with an improperly stored dose of VARIVAX lot # M037642 with an expiration date 01-SEP-2018 for prophylaxis (dose and route of administration were not reported). There was no adverse effect reported. Administered dose of VARIVAX experienced the temperature excursion of 19 degrees Fahrenheit for 102 hours. There was previous temperature excursion of 9 degrees Fahrenheit for 15 minutes. A digital data logger was not involved.  This is one of several reports received from the same reporter.  Additional information has been requested.; Sender's Comments:  US-009507513-1704USA003591:
48 hours after receiving the vaccine, I had a hive reaction (redness, slight swelling) over a roughly 7?x5? section of both of my upper arms. This is a typical allergic reaction  I have to ibuprofen, Benadryl and occasionally to something I?ve eaten (source unknown). This is a stronger reaction than I usually have. 24 hours after the shot, I had headache, muscle ache, chills, and fatigue. Those symptoms had pretty much abated about 36 hours after the shot. I did not notice the hive reaction earlier than 48 hours after the shot.
Partial -40%- sudden hearing loss with low ringing that occurred within 24 hours of H1N1 vaccine injection received at Health Services.
Diagnosed with COVID-19; Diagnosed with COVID-19; Nausea; Tired; Unable to eat; Diarrhea; This is a spontaneous report from a contactable consumer. An 80-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 08Feb2021 (15:15) (Lot number: EM9809; Expiration date was not reported) and the second dose on 01Mar2021 (Lot number: EN6203; Expiration date was not reported), both on the right arm as a single dose, with route of administration unspecified, for COVID-19 immunization at the pharmacy/drug store. Medical history included myasthenia gravis and diabetes. The patient had unspecified concomitant medications. On 05Apr2021, the patient had nausea; was tired; unable to eat; and had diarrhea. On 10Apr2021, the patient was diagnosed with COVID-19 (tested positive for SARS COV-2 RT-PCR nasal swab). The events had resulted into doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the reported events. The patient's computerized tomogram (CT) value was 16.1-33.0 on an unspecified date. The outcome of the events was not recovered.
Patient became unconscious and fell in the family room around 8 am. She seemed to have a very low blood pressure and was very pale. She had pain on her right side due to the fall. She gradually improved over the day after taking twice 400 mg Ibuprofen.
shortness of breathe; Raised BP; This is a spontaneous report from a contactable consumer (patient). A 42-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number was En6201 and expiration date was not reported), dose 1 via an unspecified route of administration, administered in arm right on 19Mar2021 at 17:00 (at the age of 42-year-old, non-pregnant) as dose 1, single for COVID-19 immunisation. Medical history reported as none and did not have allergies to medications, food, or other products. Concomitant medications included amlodipine besilate taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 19Mar2021 at 17:15, the patient experienced shortness of breath and raised bp (blood pressure). The adverse events resulted in emergency room visit/department or urgent care. The patient received treatment Epi though IV (intravenous) for the reported adverse events. The outcome of the events was resolved on an unspecified date in Mar2021.
Vial initially stored in refrigerator on 04-Jun-2022 and administered on 15-Jul-2022; No adverse event; Administered the vaccine to 346 patients after the 30 day by used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used), PRODUCT STORAGE ERROR (Vial initially stored in refrigerator on 04-Jun-2022 and administered on 15-Jul-2022) and NO ADVERSE EVENT (No adverse event) in a 73-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 15-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 15-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial initially stored in refrigerator on 04-Jun-2022 and administered on 15-Jul-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used), PRODUCT STORAGE ERROR (Vial initially stored in refrigerator on 04-Jun-2022 and administered on 15-Jul-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used) and PRODUCT STORAGE ERROR (Vial initially stored in refrigerator on 04-Jun-2022 and administered on 15-Jul-2022).    Concomitant medication information was not provided by the reporter.  Patient received half dose.  Vial was initially stored in the refrigerator on 04-Jun-2022.  Vaccine administered to 346 patients after the 30 day by used involved 35 vials. Vial did not undergo any temperature excursions.  Treatment information was not provided by the reporter.
Swelling, redness, and pain in left upper extremity. IV Vancomycin 1 gram IV for 12 hours 3/14-3/15. IV Ancet 1 gram IV for 8 hours 3/14-3/16. WBC: 11.5 on 3/13/04. Final diagnosis: Cellulitis. Review of hospital d/c summary. Please add to Box 7 the following: final diagnosis was cellulitis (CELLULITIS). Symptoms were fever of 103.1 (FEVER), rigors (CHILLS), headache (HEADACHE), muscle twitching (TWITCH), and confusion (CONFUS). Please add to Box 17  Zocor, Glucovance, Zestril, and Darvocet.
About 15 hours after vaccines developed fever 102-103, poor feeding, irritability and shaking. ER visit, fluids, defervesced went home. 6/20 developed thick green nasal discharge and continued to have fevers to 103. Last fever 1AM on 6/22. 6/23 doing much better, feeding well.
Patient received Moderna COVID vaccine on 2/3/21 and 3/3/21.  Per patient, symptoms (cough, headache, chills, fatigue, malaise, dizziness, and dyspnea) began on 9/14/21 and COVID status positive on 9/16/21. On 9/27/21, patient is admitted to our facility for acute hypoxemic respiratory failure due to COVID-19 pneumonia. Patient is discharged home today (9/29/21) with supplemental oxygen.
Approximately 35 minutes after receiving the Moderna vaccine, I experienced an unusual metallic taste in my mouth followed by severe pain to both sides of my head and significant dizziness, I also felt tingling and numbness to the lower part of my face.  The intense pain to my head (like both sides of my head were being squeezed between two plates) and dizziness lasted about 10 minutes.  At the time it occurred, I was driving and had to pull off the road due to the symptoms.  The dizziness slowly got better but my headache remained, although it wasn't as severe.  After the dizziness faded, I felt light-headed for about 30 minutes.  The strange metallic taste in my mouth lasted about 45 minutes.  I had never had an experience like that with a vaccine.
Starting in approximately June 2021, I begin noticing and experiencing more frequent urination, more frequent urge to urinate, and often with little urine. While I attributed this to my age (41 year old male at the time) I have been encouraged to submit this here.
pt. recvd. 1st vax of Hep B 06NOV90 & exp. T-100.7 for "weeks" which later tapered.On 18DEC90 pt. recvd. 2nd. vax & exp. T-100.3.
Two days following my shot I awoke with an all over body rash which was very itchy. I took Benedryl, hoping that would settle things down.  It didn?t help. I went to bed that night, and when I awoke the next morning, the rash was even worse and my hands were so swollen I could hardly bend my fingers. The itch was really severe on my hands and feet.  My husband took me to the ER, where I was treated with antihistamines and prednisone.  I was there for about 3 hours and released with a prescription for another 6 days of prednisone.  The rash , swelling and itching began to improve  after about 2 days.  The ER doctor told me I should not get the second shot.
Case number PHEH2015US026871 is a spontaneous report initially received from a nurse on 22 Dec 2015. This report refers to a 27 years old female patient. Past medical history and concomitant medications were not reported. The patient was vaccinated with FLUVIRIN (batch number: 1514501 and expiry date: May 2016) into left deltoid on 28 Oct 2015. It was reported that FLUVIRIN administered to the patient had a temperature excursion of 34 degrees. The reporter stated that she did not know why the refrigerator was out of temperature range for an unspecified amount of time overnight. She checked the temperature before she left for the day and when she arrived the next day and the temperature was fine. It was a new refrigerator and there have not been any problems since the temperature excursion. No adverse reaction was experienced by the patient following the maladministration. No further information provided. Follow up information received from the nurse on 26 Jan 2016: Reporter's comment updated.
Fever, hoarseness, coughing, swelling of the eyes + throat, fast hart beat.
Sick - stomach and back ache, migraine type headache. Lasted whole day and left me exhausted for another day.
Nursing student mistook Menactra as the diluent for the varicella and injected it subcutaneously. No problems with patient therefor no treatment needed.
booster shot; when the needle put out there is lot of blood; when the needle put out there is lot of blood/vaccine on her right arm but the problem is the needle a lot of blood coming out; there is bleeding issue; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 17 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 28Dec2021 17:00 (Lot number: FL3198) at the age of 17 years as dose number unknown (booster), single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Covid-19 vaccine (DOSE X; MANUFACTURER UNKNOWN), for COVID-19 immunization. The following information was reported: IMMUNISATION (non-serious) with onset 28Dec2021 17:00, outcome "unknown", described as "booster shot"; PRODUCT ADMINISTRATION ERROR (non-serious) with onset 28Dec2021 17:00, outcome "unknown", described as "when the needle put out there is lot of blood"; VACCINATION SITE HAEMORRHAGE (non-serious) with onset 28Dec2021 17:00, outcome "unknown", described as "when the needle put out there is lot of blood/vaccine on her right arm but the problem is the needle a lot of blood coming out; there is bleeding issue".  Additional information: It was reported that the patient went walking to that hospital that afternoon around the 12 o'clock had a Pfizer vaccine shot afternoon at 5 O'clock and basically it was given on her right arm and when the needle put out there was lot of blood and basically it was slowing on. The problem was the needle, a lot of blood was coming out and the nurse had to wipe it twice and so her concern was that whether the vaccine given inside was availed. There was bleeding issue. The reporter wanted to know whether that was the cause that compromise the booster and if the needle went inside the muscle or if that could cause the bleeding issue.  No follow-up attempts are possible. No further information is expected.
Migraine headache.  Patient has history of migraines that are well managed.  Last migraine was in January 2009.  Symptoms consistent with how migraine usually presents in patient - visual aura, severe headache, soreness of neck and upper back.  Treated with Maxalt.
Patient received Pneumovax 10-25-06, Presented 6 days later complaining of voice hoarseness 24h after the shot. Found to have (L) vocal cord paralysis after rhinoscopy. Has failed to clear 6 months after 1st presented 6/27/07-records received from physician for DOS 10/25/06-5/7/07-seen for viral cold. Impression bronchitis, asthma. Presented on 11/15/06 with C/O horseness since receiving vaccine. Increased congestion, postnasal drip. Rhinoscopy positive for left side vocal cord paralysis.  Admitted to hospital on 12/26/06 for tracheostomy 7/25/07-records received for DOS 12/28/06-1/5/07- DC DX: True vocal cord paralysis. Severe obstructive sleep apena. Diabetes. Anemia. Haemophilus influenzae pneumonia. Deconditioning. Hypertension. Dyslipidemia. History of vocal cord immobility which began suddenly late October 2006 about 2 days after Pneumovax vaccine. Continues to C/O vocal cord fatigue, near aphonia and aspirations of liquids. Emergency tracheotomy for respiratory failure.  1/1/10 follow up - still has ? voice hoarseness but mostly better. 02/02/2010 At first complete vocal cord paralysis. Currenlty he is much better but has some mild residual symptoms.
3 days, post vax, pt had rash, swollen leg, fussy but of normal gait X 2 days. Evaluated on 6/28/01.
Menstruation cycle now twice a month -HEAVY.  Previously, for the last 10 yrs, it had been once a month with only very light spotting.  Joint pain
I went to the emergency room on March 9th, after having chest pain, they perform chest x-ray, EKG, blood test. I was placed on a heart monitor for 48 hours due to irregular heart beat. My other lab and test results were normal and was told to refer back to my primary care doctor. I followed -up with my primary care after 10 days and was told to follow-up if  irregular heart beat and chest pain gets worse.
VACCINE WAS REFROZEN; ADMINISTRATION OF REFROZEN VACCINE; This spontaneous report received from a health care professional concerned a 38 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1821286, expiry: 20-MAR-2022) dose was not reported, administered on 29-JUL-2021 for prophylactic vaccination. Age at time of vaccination 38 years old. No concomitant medications were reported. On 29-JUL-2021, the patient experienced administration of refrozen vaccine. On an unspecified date, the patient experienced vaccine was refrozen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the administration of refrozen vaccine and vaccine was refrozen was not reported. This report was non-serious. This case, from the same reporter is linked to 20220537341, 20220537356, 20220537444, 20220537532, 20220537548, 20220537683, 20220537688, 20220538149, 20220538210, 20220538238, 20220538292, 20220538297, 20220538316, 20220538347, 20220538347, 20220538411, 20220538425, 20220538428, 20220538437, 20220538480, 20220538573, 20220538627, 20220538666, 20220538693, 20220538758, 20220538890, 20220539045, 20220540324, 20220540435, 20220540474, 20220540524, 20220540536, 20220540570, 20220540688, 20220540816, 20220540853, 20220541085, 20220541180, 20220541401, 20220541506, 20220537507, 20220538480, 20220540765 and 20220540814.
pt recv vax;baby began to cry w/ unusual sounding cry & cont to cry through out the day & noc w/out any lessening;apap given;
My symptoms started with a sore throat the following day. I had white patches on the left side of my throat only and my glands were swollen and very sore. I woke up Sunday feeling much worse.  I went to express care to get tested for strep and covid. Later in the day I was fatigued, had aches, chills, headache, diarrhea. The patches in my throat got much worse and I got a fever. I tested negative for strep and covid.
Heart palpitations and fatigue during the day and night, lasting now for 2 months, but initially not every day.  Symptoms got worse after second dose of Covid 19 vaccine on April 26, 2021.
SWELLING, ITCHING, SORE/ TENDERNESS, FEVER, LARGE KNOT AT THE SITE OF VACCINATION,
Information has been received from a pharmacist referring to a patient of unknown age and gender. On an unspecified date, the patient was inadvertently administered 2 doses of VARIVAX (Merck) (lot#, dose and route not provided). No adverse effect was reported. Additional information has been requested.
RECEIVED MULTIPLE VACCINATION REQUIRED FOR DEPLOYMENT. ON 21 OCTOBER AT ABOUT 1500 HOURS, RECEIVED HEPATITIS A/B (TWINRIX), Tdap (ADACEL), TYPHOID, YELLOW FEVER IN LT DELTOID ALL WITHIN 1" CIRCUMFERENCE FROM EACH OTHER. IN HIS RT DELTOID HE RECEIVED INFLUENZA VACCINE. MEMBER AWOKE AT ABOUT 0300 ON 22 OCTOBER (ABOUT 12 HOURS LATER)WITH LT ARM PAIN RADIATING DOWN ARM AND UP NECK AND WAS GIVEN TORDAL IM. SUBSEQUENTLY DEVELOPED RASH SPREADING FROM SITE OF IMMUNIZATIONS INJECTION TO FACE, CHEST AND GROIN THRU 24 OCTOBER. TREATED 24 OCTOBER WITH PREDNISONE, RANITIDINE, AND DIPHENHYDRAMINE WITH COMPLETE RESOLUTION BY 30 OCTOBER.
It was reported that a patient (3 of 6) received a Fluzone SV 2001-2002 vaccination (administration date and site information was not provided). Sometime after the vaccination (exact date not specified), the patient developed a local reaction at the injection site. Further information is requested. Linked cases : U200101055, U200101225, U200101227, U200101228, and U200101229.
Ball in area of injection, and it was warm.  It lasted for 3-4 days.
Gave SHINGRIX VX, pt stated that she "did not feel well," propped her feet up in a chair, started passing out (slumping in chair, sweating profusely), Tech called EMS and alerted store manager with Code White; EMS arrived, pt was more alert, sipping on water; pt stated that she "did not want to go to the ER." Waiver was signed with EMS. Pt called pharmacy to state she was home and doing well.
On 1/12/2021, I received the Moderna Covid vaccine in the left arm.  The following morning, 1/13/2021, I underwent a routine allergy prick test.  I have had that test in the past and responded dramatically to dust mites.  I was having the test again because I was considering getting a dog, and the dog allergens were added to the test.  As usual, I responded dramatically to the dust mite injection.  The evening of 1/13/2021, I developed tingling in the feet.  The next day, 1/14/2021, tingling went up to the knees and began in the upper limbs from the fingertips to the wrists.  Over the next days, I developed joint tenderness particularly in the upper limbs, fingers, wrists, and elbows, that made me want to massage